BI 764532
Boehringer Ingelheim
['thoracic', 'sclc']
bi 764532, bispecific dll3/cd3 igg-like t-cell engager. encouraging responses seen! 26%, 19%, 60% in sclc, epnec, lcenc, respectively. low rate of traes (4%). crs reported in 59%, mostly grade 1-2. time for thoracic oncs to learn about the management of crs ?! #asco23 
Thoracic Medical Oncologist at Georgetown University | Father/husband/immigrant | #SoMeEditor @ClinicalLung | #LCSM